TA211 Constipation (women) - prucalopride: review decision - January 2014
Review of NICE Technology Appraisal Guidance No. 211; Prucalopride for the treatment of chronic constipation in women
The Institute was proposing that TA211 should be moved to the static list.
During consultation, the majority of comments received by the Institute agreed with the proposal put forward. After consideration of all of the comments (attached as appendix A), the Institute’s Guidance Executive has decided to proceed with the proposal.
TA211 will therefore be moved to the static list. Topics on the static list can be considered for review if any new evidence becomes available that is likely to lead to a change in the existing recommendations.
This page was last updated: 23 January 2014